Kenneth Bloom, DPM
Foot & Ankle Surgery · Mooresville, NCNPI 1811983372
Payments from drug & device makers
What this record shows
This record is dominated by other: $52,165 of the $52,632 with a category attached, or 99.1%. Linvatec Corporation accounts for 99.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $46,101 and has fallen 99.5% since, to $248 in 2025. Among foot & ankle surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $3759.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$52K
- Peerless Surgical Inc.$223
- In2bones USA, LLC$111
- Bioventus LLC$50
- Smith+Nephew$42
- Melinta Therapeutics, LLC$42
What the payments were for
- Food & beverage$4681%
- Other$52,16599%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 5 | $52,165 |
| Peerless Surgical Inc. | 3 | $223 |
| In2bones USA, LLC | 1 | $111 |
| Bioventus LLC | 2 | $50 |
| Smith+Nephew | 2 | $42 |
| Melinta Therapeutics, LLC | 1 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$52,165
- Reference Toe System$111
- IBS$111
- DuaFit$111
- OS2 VP$111
How this compares
$52,632 in reported general payments places this provider in the 95th percentile of 196 foot & ankle surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 54 | $622 |
| Doxycycline Hyclate | 54 | $460 |
| Meloxicam | 95 | $271 |
| Methylprednisolone | 33 | $206 |
| Terbinafine Hcl | 15 | $198 |
| Colchicine | 18 | $140 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Mooresville
- James RobinsonMooresville$21K
- Kurt MasseyMooresville$17K
- Conor KeeleyMooresville$10K
- Alex SchaefferMooresville$7K
- Teddy MusselmanMooresville$7K
- Emily ZulaufMooresville$7K
- Garrett BielaMooresville$6K
- Robert OlsonGastonia$473K
- Austin MatthewsLumberton$279K
- Matthew DzurikWilmington$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.